港股異動 | 機構唱好 海吉亞醫療(6078.HK)逆勢漲5%
格隆匯10月10日丨海吉亞醫療(6078.HK)盤初逆勢拉昇漲5%,現報45.55港元,暫成交5880萬港元已超上個交易日全天成交額,總市值280億港元。大摩日前予海吉亞醫療“增持”評級,目標價升至65港元,較現價有40%左右漲幅。該行將2022-24年收入預測分別升1%/降4%/降3%,2025-30年收入預測上調2%-8%,與公司管理層的指引相符。國泰君安指出,公司通過內生及外延擴張不斷擴大醫院網絡,隨着可開放牀位數和單產增加,有望穩健持續增長,規模效應下盈利能力和品牌影響力不斷提升。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.